The 5-HT2 receptor agonist MK-212 reduces food intake and increases resting but prevents the behavioural satiety sequence

Pharmacology, Biochemistry, and Behavior
J C G HalfordJ E Blundell

Abstract

The 5-HT2c receptor is implicated in the relationship between serotonin and satiety. However, anorexia induced by the 5-HT2 receptor agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) has been shown to delay, not advance behaviours associated with the onset of satiety, fragmenting eating behaviour, 6-chloro-2-(1-piperazinyl)pryazine (MK-212) is also a selective agonist at the 5-HT2 receptor sites. MK-212 has greater affinity for 5-HT2c receptor sites than DOI. The effects of an ED50 dose of MK-212 (5.0 mg/kg i.p.) on the eating and other behaviours of the fasted rat were continuously monitored following the presentation of food. Continuous monitoring provides the most powerful and valid form of behavioural analysis. Temporal profiles of behaviour duration (dur) and frequency (frq) were generated. Food intake was reduced 54% by MK-212 (p < .001). The frequency of grooming was reduced (p < .01). Locomotion (dur p < .001, frq p < .001), rearing (dur p < .0005, frq p < .005) and sniffing (dur p < .05, frq p < .0001) were all reduced. The duration of resting increased (p < 0.01). This is consistent with enhanced satiety. However, the Behavioural Satiety Sequence was not present after the administration of MK-212 (5.0 mg/kg)...Continue Reading

References

Apr 1, 1978·British Journal of Pharmacology·B V ClineschmidtJ A Totaro
Sep 1, 1975·Journal of Comparative and Physiological Psychology·J AntinG P Smith
Jan 1, 1988·Psychopharmacology·A M Montgomery, P Willner
Feb 1, 1983·Physiology & Behavior·C A Hendrie, S Bennett

❮ Previous
Next ❯

Citations

Apr 12, 2005·Psychopharmacology·Zoë D Thornton-JonesPeter G Clifton
Jun 5, 2002·Physiology & Behavior·Claire M Williams, Tim C Kirkham
Sep 17, 1998·Pharmacology, Biochemistry, and Behavior·J C HalfordJ E Blundell
May 8, 2004·Behavioural Brain Research·Per NedergaardErling Mellerup
Mar 7, 2001·Diabetes, Obesity & Metabolism·M J BickerdikeC T Dourish
Jan 25, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Noelle C AnastasioKathryn A Cunningham
Dec 25, 2013·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·Jorge J Pérez MaceiraManuel Aldegunde
Nov 7, 2015·Cellular and Molecular Life Sciences : CMLS·Paige V BauerFrank A Duca
Nov 26, 2008·The Journal of Physiology·Alastair S Garfield, Lora K Heisler
Feb 15, 2011·Pharmacology, Biochemistry, and Behavior·Maria A TikhonovaAlexander V Kulikov
Sep 15, 2014·Behavioural Brain Research·Jörg-Peter Voigt, Heidrun Fink
Oct 9, 2014·Annual Review of Pharmacology and Toxicology·Daniel J Urban, Bryan L Roth
Mar 11, 2010·Pharmacology, Biochemistry, and Behavior·R J RodgersA J Tallett
Jun 4, 2002·Nutritional Neuroscience·J M Barreto MedeirosR Manhães De Castro
Nov 3, 2010·Nutritional Neuroscience·Carolina Peixoto MagalhãesRaul Manhães de Castro
Mar 15, 2006·Brazilian Journal of Biology = Revista Brasleira De Biologia·P L Cedraz-MercezL C Reis
Dec 22, 1999·Endocrine Reviews·G A Bray, F L Greenway
Apr 23, 2008·Current Protocols in Neuroscience·Simon GoodsonJohn Blundell
Jul 28, 2018·Frontiers in Physiology·Edward S Bliss, Eliza Whiteside

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.